Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis

Abstract: To examine the activity of ibrutinib in steroid-refractory chronic graft-versus-host disease (SR-cGVHD) after the US Food and Drug Administration approval, we conducted a multicenter retrospective study. Data were standardly collected (N = 270 from 19 centers). Involved organs included ski...

Full description

Saved in:
Bibliographic Details
Main Authors: Joseph Pidala, Jongphil Kim, Denise Kalos, Corey Cutler, Zachariah DeFilipp, Mary E. D. Flowers, Betty K. Hamilton, Kuo-Kai Chin, Marcello Rotta, Najla El Jurdi, Mehdi Hamadani, Gulrayz Ahmed, Carrie Kitko, Doris Ponce, Anthony Sung, Helen Tang, Nosha Farhadfar, Eneida Nemecek, Iskra Pusic, Muna Qayed, Hemalatha Rangarajan, William Hogan, Aaron Etra, Samantha Jaglowski
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Blood Advances
Online Access:http://www.sciencedirect.com/science/article/pii/S2473952924006256
Tags: Add Tag
No Tags, Be the first to tag this record!